These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens. Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391 [TBL] [Abstract][Full Text] [Related]
3. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Butterworth BE; Conolly RB; Morgan KT Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations]. Tubiana M Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515 [TBL] [Abstract][Full Text] [Related]
5. Chloroform mode of action: implications for cancer risk assessment. Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278 [TBL] [Abstract][Full Text] [Related]
6. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
7. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours. Bignold LP Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of known human carcinogens. Barrett JC IARC Sci Publ; 1992; (116):115-34. PubMed ID: 1428078 [TBL] [Abstract][Full Text] [Related]
10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [TBL] [Abstract][Full Text] [Related]
11. Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. Goldsworthy TL; Morgan KT; Popp JA; Butterworth BE Prog Clin Biol Res; 1991; 369():253-84. PubMed ID: 1946524 [TBL] [Abstract][Full Text] [Related]
13. The results of assays in Drosophila as indicators of exposure to carcinogens. Vogel EW; Graf U; Frei HJ; Nivard MM IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive approach for integration of toxicity and cancer risk assessments. Butterworth BE; Bogdanffy MS Regul Toxicol Pharmacol; 1999 Feb; 29(1):23-36. PubMed ID: 10051416 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment. Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238 [TBL] [Abstract][Full Text] [Related]
17. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis. DiGiovanni J; Rho O; Xian W; Beltràn L Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243 [TBL] [Abstract][Full Text] [Related]
18. Relationship of chromosome changes to neoplastic cell transformation. DiPaolo JA; Popescu NC Am J Pathol; 1976 Dec; 85(3):709-38. PubMed ID: 826168 [TBL] [Abstract][Full Text] [Related]
19. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens. Butterworth BE Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901 [TBL] [Abstract][Full Text] [Related]
20. [The role of cell proliferation in carcinogenesis]. Kostka G Rocz Panstw Zakl Hig; 1998; 49(3):265-78. PubMed ID: 9930019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]